MDGL
MADRIGAL PHARMACEUTICALS, INC. · Healthcare · Market cap $10.8B
Insiders sold $7.9M net in the last 90 days ·2 sellers, 0 buyers· 2 of 4 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 11, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$81.5M
reported sales (SEC code S)
Unique Insiders
9
in the rolling window
Latest filing
Sep 11, 2026
Sibold William John
MADRIGAL PHARMACEUTICALS, INC. (MDGL) has 39 SEC Form 4 filings (233 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Sep 11, 2026.
Inside the rolling window, 9 insiders at MADRIGAL PHARMACEUTICALS, INC. reported no open-market purchases and 27 open-market sales totaling $81.5M. The most active filer is President and CEO Sibold William John with 6 filings. Insiders have net sold $11.8M over the trailing 6 months. The most recent open-market filing is a sale of 6,362 shares by President and CEO Sibold William John, dated Sep 9, 2026, worth $3.4M.
- Industry:Biotechnology
- CEO:William J. Sibold
- Employees:915
- HQ:West Conshohocken, PA, US
- IPO:2007-02-06
| Source | |||||||
|---|---|---|---|---|---|---|---|
| President and CEO | Sale | 6,362 | $3.4M | Sep 11 | -12.5% | SEC ↗ | |
| President and CEO | Sale | 5,221 | $2.8M | Sep 11 | — | SEC ↗ | |
Kelley Shannon TFirst in 6 months | General Counsel | Sale | 664 | $342K | Aug 20 | — | SEC ↗ |
Sibold William JohnFirst in 5 months | President and CEO | Sale | 2,500 | $1.4M | Jul 21 | — | SEC ↗ |
| Chief Medical Officer | Sale | 1,042 | $517K | Jun 1 | — | SEC ↗ | |
Levy Richard SFirst in 6 months | Director | Sale | 5,682 | $2.9M | May 22 | — | SEC ↗ |
Soergel DavidFirst filing | Chief Medical Officer | Sale | 844 | $435K | May 18 | — | SEC ↗ |
| EVP and CFO | Sale | 1,982 | $854K | Mar 6 | — | SEC ↗ | |
| Chief Commercial Officer | Sale | 419 | $181K | Mar 6 | — | SEC ↗ | |
| General Counsel | Sale | 360 | $155K | Mar 6 | — | SEC ↗ | |
| President and CEO | Sale | 1,663 | $718K | Mar 6 | — | SEC ↗ | |
| Director | Sale | 491 | $212K | Mar 6 | — | SEC ↗ | |
| EVP and CFO | Sale | 1,183 | $505K | Mar 2 | — | SEC ↗ | |
| Chief Commercial Officer | Sale | 910 | $449K | Jan 26 | — | SEC ↗ | |
| President and CEO | Sale | 1,577 | $777K | Jan 26 | — | SEC ↗ | |
| Director | Sale | 647 | $319K | Jan 26 | — | SEC ↗ | |
Kelley Shannon TFirst filing | General Counsel | Sale | 692 | $344K | Jan 20 | — | SEC ↗ |
| Director | Sale | 2,238 | $1.1M | Jan 20 | — | SEC ↗ | |
| Director | Sale | 24,800 | $13.0M | Jan 13 | — | SEC ↗ | |
| Director | Sale | 18,650 | $9.7M | Jan 13 | — | SEC ↗ | |
FRIEDMAN PAUL AFirst filing | Director | Sale | 24,800 | $13.7M | Dec 12 | — | SEC ↗ |
Taub RebeccaFirst filing | Director | Sale | 18,650 | $10.3M | Dec 12 | — | SEC ↗ |
Sibold William JohnFirst filing | President and CEO | Sale | 2,400 | $1.4M | Dec 4 | — | SEC ↗ |
Dier MardiFirst filing | EVP and CFO | Sale | 4,173 | $2.4M | Dec 3 | — | SEC ↗ |
Huntsman CaroleFirst filing | Chief Commercial Officer | Sale | 1,958 | $1.1M | Nov 21 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading MDGL 1 all-time
- DRep. Daniel GoldmanSale$1,001 - $15,0002023-04-10
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does MDGL have?
MADRIGAL PHARMACEUTICALS, INC. (MDGL) has 39 SEC Form 4 filings (233 transaction rows) in the rolling 365-day window, disclosed by 9 distinct insiders. Most recent filing: Sep 11, 2026.
When was the most recent SEC Form 4 filing for MDGL?
The most recent Form 4 filing for MDGL on Tracefour is dated Sep 11, 2026.
Who is the most active insider at MDGL?
The most active SEC Form 4 filer at MDGL in the rolling window is President and CEO Sibold William John, with 6 filings.
What is the net insider flow at MDGL over the last 6 months?
Over the trailing 180 days, insiders at MDGL have net sold $11.8M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at MDGL in the current window?
Inside the rolling window, insiders at MDGL bought $0 and sold $81.5M based on SEC Form 4 filings.
Can I get alerts for MDGL insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at MADRIGAL PHARMACEUTICALS, INC. (MDGL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
MADRIGAL PHARMACEUTICALS, INC. is in the Healthcare sector.